Aprille Espinueva

Aprille Espinueva is a highly skilled professional in clinical development and medical affairs, currently serving as the Director of Clinical Development - Metabolism at Corcept Therapeutics since October 2022. In addition to this role, Espinueva works as a Clinical Pharmacist - Per Diem at Zuckerberg San Francisco General Hospital and Trauma Center and as an Adjunct Professor at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. From September 2014 to October 2022, Espinueva held various positions at Gilead Sciences, including Associate Director of Medical Affairs for COVID-19 and Senior Manager for Liver Disease/Fibrosis. Previous experience includes clinical pharmacist roles at UCSF Medical Center and San Francisco General Hospital, along with a Pharmacy Practice Residency at Sharp HealthCare. Espinueva holds a Doctorate in Pharmacy from the University of California, San Francisco, and a B.S. in Biochemistry from the University of San Francisco.